Abcuro
abcuro.com
BiotechHealthcare
Abcuro specializes in the precision targeting of highly cytotoxic T cells to treat autoimmune diseases. Its approach aims to offer targeted therapies that address the underlying causes of these conditions, potentially improving patient care.
Founded
2015
Total Funding
$100M+
Total Rounds
3
First Raise
Aug 18, 2023
Latest Raise
Aug 18, 2026
Get notified when Abcuro and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
Showing 1 of 3 rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/18/2026 | |||
2 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
Abcuro 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free